4//SEC Filing
HANSON GREGORY P 4
Accession 0001415889-18-000538
CIK 0001109196other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:24 PM ET
Size
9.2 KB
Accession
0001415889-18-000538
Insider Transaction Report
Form 4
HANSON GREGORY P
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-04-02+7,021→ 116,735 total - Exercise/Conversion
Restricted Stock Unit
2018-04-02−7,021→ 0 total→ Common Stock (7,021 underlying) - Tax Payment
Common Stock
2018-04-02−2,428→ 114,307 total
Footnotes (4)
- [F1]Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015.
- [F2]Represents withholding by the Issuer of shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the above conversion of restricted stock units into common stock.
- [F3]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- [F4]Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeother
Related Parties
1- filerCIK 0001186120
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:24 PM ET
- Size
- 9.2 KB